Jyong Biotech (NASDAQ:MENS) Shares Gap Down - Time to Sell?

Key Points

• Jyong Biotech Ltd. shares gapped down from a previous close of $65.62 to $62.52 at market open, with the last traded price at $57.00.
• Analysts at Wall Street Zen have upgraded Jyong Biotech to a "hold" rating, signaling a potential change in investment strategy.
• The company's 50-day moving average stands at $38.03, indicating recent volatility in stock performance.

Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report)'s stock price gapped down prior to trading on Monday . The stock had previously closed at $65.62, but opened at $62.52. Jyong Biotech shares last traded at $57.00, with a volume of 31,474 shares trading hands.

Analyst Ratings Changes

Separately, Wall Street Zen raised Jyong Biotech to a "hold" rating in a research note on Monday, June 30th.

Jyong Biotech Stock Performance

The firm's 50-day moving average is $38.03.

About Jyong Biotech

OUR MISSION We endeavor to develop and supply first-class innovative drugs to meet our customers' health needs. We seek to be a valuable business organization that is held in high esteem by the public. We are a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU, and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.